Current predictors of clinical outcomes after pulmonary thromboendarterectomy (PTE) in patients with chronic thromboembolic pulmonary hypertension (CTEPH) are largely limited to preoperative clinical characteristics...

Lung transplantation remains an important therapeutic option for idiopathic pulmonary arterial hypertension (IPAH), yet short-term survival is the poorest among the major diagnostic categories...

To explore the genetic causal association between pulmonary artery hypertension (PAH) and iron status through Mendelian randomization (MR), we conducted MR analysis using publicly available genome-wide association study (GWAS) summary data...

Information on factors leading to pulmonary arterial hypertension (PAH) treatment discontinuation is limited...

Cardiac catheterization remains the gold standard for the diagnosis and management of pediatric pulmonary hypertension (PH)...

Pulmonary arterial hypertension (PAH) is driven by pathologies associated with increased metabolism such as pulmonary revascularization, vasoconstriction and smooth muscle cell proliferation in pulmonary artery wall...

Reduced exercise capacity in pulmonary hypertension (PH) significantly impacts quality of life...

Pulmonary thromboembolism caused by thrombi blocking major pulmonary artery and its branches, is a frequently encountered phenomenon and an important cause of high morbidity and mortality in lung diseases and may develop into persistent pulmonary hypertension (PH)...

Right ventricular (RV) dysfunction in pulmonary arterial hypertension (PAH) is associated with poor outcomes...